GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

The developing intestinal immune system in Yersinia enterocolitica infection

$229,500
Rebecca D Adkins · University Of Miami School Of Medicine · R21 · FY2009 · AI

Impact of nucleotide metabolism on enterococcal antibiotic resistance

$229,500
Christopher J Kristich · Medical College Of Wisconsin · R21 · FY2014 · AI

Redefining fatty acid degradation by Staphylococcus aureus

$229,500
Jeffrey Lee Bose · University Of Kansas Medical Center · R21 · FY2021 · AI

Targeted-delivery of small interference RNA against anthrax

$229,500
Mingtao Zeng · Texas Tech University Health Scis Center · R21 · FY2016 · AI

Pyroptotic Macrophages Traps Against Shigella Infection

$229,500
Youssef Aachoui · Univ Of Arkansas For Med Scis · R21 · FY2023 · AI

Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes

$229,472
Chengcang Charles Wu · Intact Genomics, Inc. · R43 · FY2018 · AI

Targeting a novel Hsp70 substrate binding mode for potential treatment of gonorrhea infection

$229,365
Qinglian Liu · Virginia Commonwealth University · R21 · FY2018 · AI

Core--Immunomicroscopy

$229,336
University Of Texas San Antonio · P01 · FY2005 · AI

Clinical Studies Of Abnormal Host Defense

$229,325
John I Gallin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

DeADP-ribosylation of host targets mediated by a bacterial effector

$229,276
Chittaranjan Das · Purdue University · R21 · FY2023 · AI

ESBL-triggered exponential amplification for culture-free phenotypic detection of MDR pathogens

$229,265
Ian M White · Univ Of Maryland, College Park · R21 · FY2020 · AI

Surface Active Polyelectrolyte Nanomedicine for Treatment of Lung Infections in Cystic Fibrosis

$229,222
Charles M. Roth · Rutgers, The State Univ Of N.J. · R21 · FY2020 · AI

A Mechanistic Understanding of Malaria Resistance: Integrating Laboratory and Computational Approaches

$229,172
Brandon Ogbunugafor · University Of Vermont & St Agric College · P20 · FY2019 · GM

Identifying mucin O-glycans in the regulation of Staphylococcus aureus pathogenesis

$229,150
Katharina Ribbeck · Massachusetts Institute Of Technology · R21 · FY2023 · AI

Glycosylated Atomically-Precise Gold Clusters: Design, Synthesis and Antimicrobial Activity

$229,100
Mingdi Yan · University Of Massachusetts Lowell · R21 · FY2019 · AI

PFOR inhibitor amixicile for treatment of drug resistant parasites and bacteria

$229,100
Paul Stokes Hoffman · University Of Virginia · R21 · FY2014 · AI

A New Paradigm for HIV Treatment: Targeted Degradation of HIV Reverse Transcriptase via the Ubiquitin-Proteasome Pathway

$229,049
Robert C Reynolds · University Of Alabama At Birmingham · R21 · FY2022 · AI

The targets of phagocytic superoxide in Salmonella

$229,015
James M. Slauch · University Of Illinois At Urbana-Champaign · R21 · FY2015 · AI

Siderophore-based antibiotics: consequences for the microbiota and bacterial pathogens

$228,963
Elizabeth M Nolan · Massachusetts Institute Of Technology · R21 · FY2016 · AI

GENETIC ANALYSIS OF ENTEROCOCCI

$228,929
University Of Texas Hlth Sci Ctr Houston · R21 · FY2000 · AI

Molecular confirmation of tuberculosis treatment

$228,926
Gerard A Cangelosi · University Of Washington · R21 · FY2019 · AI

Pseudomonas antibodies with designed glycans

$228,758
Andrew C Hiatt · Mapp Biopharmaceutical, Inc. · R43 · FY2015 · AI

Analysis of ADAM10 in infection-associated MODS

$228,750
Juliane Bubeck Wardenburg · Washington University · R21 · FY2017 · HD

Role of TGF-Beta signaling in the Drosophila immune response against nematode-bac

$228,750
Ioannis Eleftherianos · George Washington University · R56 · FY2014 · AI

Microbiota pancreas interactions during cancer

$228,750
June Louise Round · University Of Utah · R21 · FY2021 · CA